





Background:  Experimental studies have shown that gabapentin can reduce neuronal injury in the setting of cerebral 
ischemia, but the mechanisms have not yet been clearly determined.  This study was conducted to determine 
whether gabapentin pretreatment altered expression levels of heat shock protein 70 and reduced acute phase 
neuronal injury in rats subjected to transient focal cerebral ischemia/reperfusion.
Methods:  Forty male Sprague-Dawley rats (260-300 g) were randomly assigned to one of four groups (saline-treated, 
or 0.1, 0.5, or 5 mg/kg gabapentin group).  In all animals, focal cerebral ischemia was induced by intraluminal middle 
cerebral artery occlusion for 1 hour.  Th   e animals of the gabapentin groups were pretreated with a single intravenous 
administration of gabapentin 20 minutes before ischemic insults.  The infarct volume, brain edema and motor 
behavior defi  cits were analyzed 24 hours after ischemic insult.  Caspase-3- reactive cells and cells showing Hsp70 
activity were counted in the caudoputamen and fronto-parietal cortex.
Results:  The infarction ratio was significantly decreased in the 5 mg/kg gabapentin group (P < 0.05) and brain 
edema ratios were signifi  cantly reduced in the 0.1 mg/kg, 0.5 mg/kg, and 5 mg/kg gabapentin groups 24 hours after 
ischemia/reperfusion injury (P < 0.05). Th   ere were more Hsp70-reactive cells in the 5 mg/kg gabapentin group than 
in the saline group in both the caudoputamen and fronto-parietal cortex (P < 0.05).
Conclusions:  These results indicate that gabapentin may have a neuroprotective effect and can reduce early 
neuronal injury caused by focal cerebral ischemia/reperfusion; this may be mediated by expression of Hsp70. 
However, gabapentin pretreatment did not prevent caspase-dependent apoptosis.  (Korean J Anesthesiol 2010; 58: 
184-190)
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    Gabapentin, 1-(aminomethyl)cyclohexane acetic acid, is a 
structural analogue of the neurotransmitter γ-aminobutyric 
acid (GABA) [1]. Gabapentin was introduced in 1993 as an 
adjuvant anticonvulsant drug for the treatment of refractory 
partial seizures [2]. Experimental stuedies have shown that 
gabapentin can reduce neuronal injury in the setting of cerebral 
ischemia [3,4]. 
    Although gabapentin was originally modeled based on the 
structure of GABA, the drug does not modulate GABA receptor 
function in the manner of conventional GABAergic drugs, 
and gabapentin is inactive at GABA receptors. The drug has 
been shown to increase GABA content in neuronal tissues 
and to bind to the α 2δ  subunit of calcium channels [5]; the 
biological effects of gabapentin are largely attributable to the 
selective inhibition of high-voltage-activated calcium channels 
containing the α 2δ-1 subunit [6]. It has been postulated that 
neuroprotective effects of gabapentin might be related to 
changes in glutamate synthesis and metabolism [1]. A recent 
study showed that the in vivo neuroprotection associated with 
gabapentin was directly attributable to antiseizure eff  ects and 
not to a direct cellular neuroprotective mechanism [4], but 
details of the cellular model of gabapentin action remain to be 
determined.
    Th   is study was conducted to determine whether gabapentin 
pretreatment altered the expression of heat shock protein 70 
and reduced acute phase neuronal injury in rats subjected to 
transient focal cerebral ischemia/reperfusion.
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    This study was performed with the approval of our Institu-
tional Animal Care and Use Committee, and in accordance with 
NIH guidelines for the care and use of laboratory animals. Adult 
male Sprague-Dawley rats weighing 260-300 g were used. Th  e 
rats were housed at constant humidity and temperature with a 
12-hour light/dark cycle and free access to food and water. Rats 
were randomized into four groups (10 rats per group); these 
were a saline-treated control group (CG), and groups receiving 
0.1, 0.5, and 5 mg/kg of gabapentin pretreatment (0.1 GG, 0.5 
GG, and 5 GG). 
    Rats were anesthetized with zoletil 12.5 mg and xylazine 
3 mg intraperitoneally and respiration was maintained 
spontaneously. Core body temperature was monitored using 
a rectal probe and was maintained at 37.0 ± 0.5
oC employing 
a heating pad (Homeothermic Blanket System, Harvard 
Apparatus Inc., USA) during all experiments. Indwelling i.v. 
cannulas (BD Angiocath Plus
TM, 0.75 in, 0.7 × 19 mm, Becton 
Dickinson, Korea) were placed into the left femoral veins of all 
animals to permit drug delivery. 
    Focal cerebral ischemia was induced by occluding the left 
middle cerebral artery (MCA) as described previously [7]. 
In brief, under an operating microscope, the left carotid 
bifurcation was exposed through a midline cervical incision. 
Th   e external carotid was ligated distally and the branches were 
coagulated. An arteriotomy was made in the external carotid 
allowing the introduction of a 4-0 surgical nylon monofi  lament 
suture (Johnson & Johnson, Belgium) with the tip rounded by 
heating near a fl  ame. Th  e  fi  lament was gently advanced into the 
internal carotid artery 18-20 mm past the carotid bifurcation 
until a slight resistance was felt, thereby occluding the origin 
of the MCA. Sixty minutes after MCA occlusion (MCAO), 
reperfusion was allowed by withdrawal of the suture thread 
until the tip cleared the internal carotid artery.
    Rats of the gabapentin pretreatment groups received 0.1, 
0.5, or 5 mg/kg gabapentin (Sigma-Aldrich, USA) dissolved 
in physiologic saline 20 minutes before the onset of middle 
cerebral artery occlusion. Control rats received 100 μl 
physiologic saline.
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    Th   e neurologic status of each rat was carefully evaluated in 
surviving animals at 1 and 3 days after MCAO. Neurological 
defects were determined using a modifi  ed Bederson’s scoring 
system [8]. Each rat was held gently by the tail, suspended 
1 m above the floor, and forelimb flexion observed. Control 
rats extended both forelimbs toward the floor. Rats that 
extended both forelimbs in this manner and that had no 
other neurological deficits were assigned grade 0. Rats with 
any amount of consistent forelimb fl  exion contralateral to the 
injured hemisphere and no other abnormality were graded 1. 
Rats were placed on a large sheet of soft, plastic-coated paper 
that could be gripped fi  rmly by the claws. With the tail held by 
hand, a gentle lateral pressure was applied behind the shoulder 
of each rat until the forelimbs slid several inches. Rats with 
reduced resistance to lateral push toward the paretic side were 
graded 2. Rats were then allowed to move about freely and 
were observed for circling behavior. Rats that circled toward the 
paretic side when the tail was pulled were graded 3, and rats 
that circled toward the paretic side consistently without any 
stimulation were graded 4.
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    After neurological evaluation, rats were randomly chosen 
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and decapitated. The brain was quickly removed and cut into 
2-mm-thick coronal blocks. Brain slices were immersed in a 
2% (w/v) solution of 2,3,5-triphenyltetrazolium chloride in 
normal saline at 37
oC for 30 minutes and next fi  xed in 10% (v/
v) phosphate-buff  ered formalin at 4
oC. Th   e stained brain slices 
were photographed using a CCD video camera and the size of 
each infarct was calculated using an Image Analysis System 
(Image J software, National Institutes of Health, USA). Infarct 
area was expressed as the percentage of infarcted area with 
reference to the area of the ipsilateral ischemic hemisphere and 
hemispheric swelling was calculated as the percentage increase 
in the size of the ipsilateral hemisphere compared with the 
contralateral intact hemisphere [9]. 
*NVOPIJTUPDIFNJDBMBOBMZTJT
    Brain tissues were sectioned at a thickness of 4 μm and cells 
showing caspase-3 and HSP70 activity were counted.
    A commercial kit (Sigma Statin
⡴ Cleaved Caspase-3 (Asp175) 
IHC kit, Cell Signaling Technology, USA) was used to assess the 
activity of caspase-3 following the manufacturer’s instructions. 
Deparaffinized and rehydrated sections were immersed in 
0.01 M sodium citrate buff  er (pH 6.0), heated at a temperature 
less than the boiling point for 10 minutes, and cooled for 30 
minutes to permit antigen unmasking. Next, 1-2 drops of 
peroxidase quench solution were applied to each slide. After 
washing in distilled water and phosphate-buffered saline 
(PBS), 1-3 drops of blocking solution was applied followed by 
1-3 drops of primary antibody or negative control solution. 
After 24 hours incubation, each slide was washed in PBS and 
biotinylated secondary antibody was applied for 30 minutes. 
Each slide was washed in PBS, premixed AB reagent was added, 
and a substrate-chromagen mixture was next applied. Staining 
was monitored until sections turned red-brown in color. After 
counterstaining with hematoxylin, slides were dehydrated in 
ethanol, treated with a permanent mounting medium, and a 
coverslip applied.
    Anti-Hsp70 antibody (HSP70 Antibody #4872, Cell Signaling 
Technology, USA), at a 1 : 50 dilution, was used to assess Hsp70 
levels as described by the manufacturer. Deparaffinized and 
rehydrated sections were immersed in 10 mM sodium citrate 
buffer (pH 6.0) and heated at a temperature less than boiling 
for 10 minutes before cooling for 30 minutes to achieve antigen 
unmasking. Next, slides were washed in distilled water three 
times. Slides were incubated in 3% (v/v) hydrogen peroxide 
solution for 10 minutes, washed in distilled water and Tris-
buffered saline (TBS)/0.1% (v/v) Tween-20 (TBST), and 100-
400 μL blocking solution was applied for 1 hour at room 
temperature; 100-400 μL primary antibody was next added. 
Each slide was then incubated at 4
oC overnight, washed three 
times in TBST, and biotinylated secondary antibody diluted in 
TBST, according to the manufacturer’s recommendation, was 
next applied for 30 minutes at room temperature. After washing 
in TBST, AB reagent was added, followed by a substrate-
chromagen mixture, and staining was monitored until color 
development was evident. After counterstaining in hematoxylin, 
each slide was dehydrated in ethanol, and a permanent moun-
ting medium and a coverslip were applied.
    Caspase-3- and Hsp70-reactive cells were counted under a 
light microscope in high-power fields (×400) in three random 
and nonoverlapping 1 mm
2-sized regions in the caudoputamen 
(ischemic core) and the fronto-parietal cortex (the penumbra).
4UBUJTUJDBMBOBMZTJT
    All data are expressed as medians with interquartile ranges. 
The chi-squared and Fisher’s exact tests were applied for 
intergroup comparisons of death rate and neurological scoring. 
Diff  erences between infarcted areas, edema ratio, and numbers 
of caspase-3- and Hsp70-reactive cells between groups were 
analyzed with the Kruskal-Wallis test. A P value less than 0.05 
was considered signifi  cant.
3FTVMUT
    Twenty-four hours after transient MCA occlusion/reperfusion, 
a well-defined pale and collapsed infarct area was seen in 
the cerebral hemisphere (Fig. 1). Neurologic scores were not 
signifi  cantly diff  erent between groups. 
Fig. 1. Middle cerebral artery occlusion/reperfusion-induced brain inju-
ries are shown. Representative images of 2,3,5-triphenyltetra  zolium 
chloride-stained sections from saline- and gabapentin-treated ani-
mals. (A: Saline treated control group, B: 0.1 mg/kg gabapentin group, C: 
0.5 mg/kg gabapentin group, D: 5 mg/kg gabapentin group). A well-
defined pale and collapsed area, considered to be an infarction, is 
seen in the left hemisphere.187 www.ekja.org
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    The mean infarct area in rats pretreated with 5 mg/kg 
gabapentin was signifi  cantly less than in saline-treated rats (P 
< 0.05), but was not significantly smaller than the areas in 0.1 
mg/kg and 0.5 mg/kg gabapentin-treated animals. Th  e  edema 
ratios of gabapentin- pretreated rats were signifi  cantly reduced 
compared with those of saline-treated rats (P < 0.05) (Fig. 2).
    Th   e number of caspase-3 reactive cells in gabapentin-treated 
rats was not significantly different from numbers in saline-
treated rats in either the caudoputamen or fronto-parietal 
cortex. There were more Hsp70-expressing cells in the 5 mg/
kg gabapentin group than in control animals, both in the 
caudoputamen and fronto-parietal cortex (P < 0.05) (Fig. 3-5).
%JTDVTTJPO
    After transient MCA occlusion/reperfusion, gabapentin, 
particularly at 5 mg/kg, reduced infarct volume and cerebral 
edema in all treated groups. Moreover, the number of cells 
showing Hsp70 reactivity increased in the 5 mg/kg gabapentin 
groups. However, gabapentin did not cause a decrease in the 
number of caspase-3 reactive cells. These results indicate 
that gabapentin pretreatment can mitigate early brain injury 
induced by MCA occlusion/reperfusion in the rat and that 
the mechanism of neuroprotection is related to expression of 
Hsp70.
Fig. 3. Th   e number of caspase 3- reactive cells in the caudoputamen and the fronto-parietal cortex following cerebral ischemia/reperfusion in-
jury. Th   e boxes are interquartile ranges; thick lines are medians, and error bars are the 10th and 90th percentiles. Th   ere were no signifi  cant dif-
ferences among the groups. °: Extreme examples over three-fold each box value. CG: saline treated control group, 0.1 GG: 0.1 mg/kg gabapentin 
group, 0.5 GG: 0.5 mg/kg gabapentin group, 5 GG: 5 mg/kg gabapentin group.
Fig. 2. Infarct ratios and edema ratios measured 24 hours after cerebral ischemia/reperfusion injury. An infarct ratio was calculated as the per-
centage of the size of the infarcted tissue area with reference to the size of the ipsilateral hemisphere. Each edema ratio was calculated as the 
percentage of the size of the ischemic hemisphere with reference to that of the contralateral normal hemisphere. Th   e boxes show interquartile 
ranges; the thick lines are medians and the error bars are the 10th and 90th percentiles. *P < 0.05 compared with the saline group. °: Extreme 
examples of over three-fold each box value. CG: saline treated control group, 0.1 GG: 0.1 mg/kg gabapentin group, 0.5 GG: 0.5 mg/kg gabapen-
tin group, 5 GG: 5 mg/kg gabapentin group.188 www.ekja.org
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    Although the cellular mechanisms of gabapentin pharma-
cological action are not well understood, several hypotheses 
have been proposed, suggesting that different properties 
account for the anticonvulsant, antinociceptive, anxiolytic, 
and neuroprotective activities of gabapentin in animal models 
[1,10,11]. A possible pharmacologic effect of gabapentin is 
modulation of calcium currents by selective drug binding to the 
auxiliary subunit of voltage-dependent calcium channels [6], 
Fig. 5. Histopathologic fi  ndings in the caudoputamen (A) and the fronto-parietal cortex (B) following cerebral ischemia/reperfusion injury. 
Representative microscopic images of caspase-3- (white arrow) and Hsp70-reactive (black arrow) cells in a saline-treated rat. Large and small 
boxes show 100× and 400× magnifi  cations, respectively. Scale bars = 200 μm and 100 μm in insets. P < 0.05 compared with the saline-treated group.
Fig. 4. Th   e number of Hsp70- reactive cells in the caudoputamen and the fronto-parietal cortex following cerebral ischemia/reperfusion injury. 
Th   e boxes are interquartile ranges; thick lines are medians, and error bars are the 10th and 90th percentiles. °: Extreme examples over three-
fold each box value. *P < 0.05 compared with the saline-treated group. CG: saline treated control group, 0.1 GG: 0.1 mg/kg gabapentin group, 0.5 
GG: 0.5 mg/kg gabapentin group, 5 GG: 5 mg/kg gabapentin group.189 www.ekja.org
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and it has been postulated that the neuroprotective effects of 
gabapentin might arise from changes in glutamate metabolism 
[1]. As the ischemic pathway overlaps signifi  cantly with seizure 
processes, anticonvulsants have been proposed as possible 
neuroprotective agents [12]. It has been reported that high-dose 
gabapentin significantly decreased acute seizures frequency 
and reduced brain atrophy in immature mice receiving 
unilateral carotid artery ligation [3]. Williams and colleagues 
[4] reported that gabapentin significantly reduced infarct 
volume and that the neuroprotective eff  ect of gabapentin was 
attributable to an antiseizure property, and not to an eff  ect on 
cellular mechanisms. In the present study we administered 
gabapentin intravenously 20 minutes before brain injury 
induced by transient MCA occlusion/reperfusion and found a 
signifi  cant reduction in infracted area in the 5 mg/kg gabapentin 
group. The cerebral brain edema ratio decreased significantly 
in all gabapentin-treated animals compared with the control 
group. The present study showed that neuroprotective effects 
were seen after administration of lower doses of gabapentin, 
compared with doses reported previously [13,14] and it may 
therefore be postulated that cellular mechanisms other than 
antiseizure efficacy, such as overexpression of Hsp70 and 
prevention of cerebral edema, are relevant to drug action. 
    Another explanation for the neuroprotective eff  ects of lower 
gabapentin doses might involve the route of administration. 
It may be expected that effective therapeutic blood levels 
in the central nervous system can be more rapidly and 
reliably achieved by intravenous injection rather than oral, 
intraperitoneal, or subcutaneous administration. 
    Th   e extent to which cell death during stroke involves apoptosis, 
necrosis, or a combination of both, remains controversial 
[15,16]. Of the potential pathways for implementation of 
apoptosis, activation of caspases, a family of cysteine aspartate 
proteases, is involved both in the signaling cascade and in 
execution of apoptosis by degradation of key intracellular 
proteins [17]. In the present study, the number of caspase-
3-reactive cells in gabapentin- pretreatment groups was not 
significantly different from that in the saline-treated control 
group. Th   is indicates that delayed neuronal cell death triggered 
by apoptosis cannot be prevented by gabapentin.
    The number of cells showing Hsp70 activity in the 5 mg/kg 
gabapentin-treated group was significantly greater than in 
control animals. When it is considered that both infarct size 
and cerebral edema level were significantly decreased in the 
same group, this indicates that the neuroprotection aff  orded by 
gabapentin is related to overexpression of Hsp70. Th  is  protein, 
a member of an evolutionarily conserved constitutive and/
or inducible protein family acting as molecular chaperones, 
is by far the best-studied of the ATP-dependent chaperone 
proteins and is induced by specific types of stress, including 
heat, oxidative challenge, protein cross-linking, and exposure 
to heavy metals [18]. Although the mechanism by which Hsp70 
affords neuroprotection from cerebral ischemia was initially 
attributed to chaperone activity, recent work has suggested that 
Hsp70 may also directly interfere with cell death pathways such 
as apoptosis and necrosis and may also modulate infl  ammation 
[19-23]. However, in the present study, the number of caspase-
3-reactive cells in gabapentin-pretreatment groups did not 
diff  er from levels in control animals. 
    Hemispheric brain edema in rats of gabapentin-pretreatment 
groups was less than seen in control rats. In addition to neuronal 
cell death, cerebral microvessels are targeted in cerebral disease 
states including focal ischemia, and this may derive from the 
rapid microvascular response to such ischemia, indicating that 
cerebral microvessels and their neighboring neurons may be 
associated in a neurovascular unit [24]. However, to the best of 
our knowledge, no previous study has investigated the effects 
of gabapentin on cerebral edema associated with endothelial 
disruption after ischemic brain injury in an animal model. 
Th   erefore, reduced edema in gabapentin-treated rats might be 
explained by an inhibitory effect of gabapentin on N-methyl-
D-aspartate-induced excitotoxicity and eff  ects on ion channels 
such as the voltage-gated sodium and calcium channels, rather 
than a protective drug eff  ect on the blood-brain barrier [25,26].
    In conclusion, gabapentin pretreatment signifi  cantly reduced 
infarct volume and cerebral edema after focal cerebral ischemia 
induced by transient MCA occlusion/reperfusion in the rat and 
increased the number of cells showing Hsp70 reactivity. Th  ese 
results indicate that gabapentin may have a neuroprotective 
effect and can reduce early neuronal injury caused by focal 
cerebral ischemia/reperfusion, and this may be mediated by 
expression of Hsp70. However, gabapentin pretreatment did 
not prevent the caspase-dependent apoptosis. As gabapentin 
is drug used in clinics, these results strongly support a potential 
use in clinical therapy for ischemic cerebrovascular disease.
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